Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin
- 1 February 2011
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 81 (3) , 388-395
Abstract
No abstract availableKeywords
Funding Information
- NIH (UO1 AI074503-01, R21 AI077081-01A1, UO1 AI070330-01)
This publication has 51 references indexed in Scilit:
- Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulationImmunobiology, 2011
- A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola VirusJournal of Biological Chemistry, 2010
- Recognition of Mannosylated Ligands and Influenza A Virus by Human Surfactant Protein D: Contributions of an Extended Site and Residue 343,Biochemistry, 2009
- Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein DRespiratory Research, 2008
- Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2PLOS ONE, 2007
- Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung DiseaseProceedings of the American Thoracic Society, 2007
- Burn Injury Reveals Altered Phenotype in Mannan-Binding Lectin-Deficient MiceJournal of Investigative Dermatology, 2007
- Assembly and budding of influenza virusVirus Research, 2004
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Collectins: collagenous C-type lectins of the innate immune defense systemImmunology Today, 1994